DNTH vs PODD · rev $6.2M vs P/E 34, rev $2.07B
Dianthus Therapeutics Inc. (DNTH) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
DNTH currently screens at market cap $4.40B. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the DNTH and PODD stock pages for the full models.
Not investment advice.